ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS

The data from a number of clinical trials investigating a once-yearly infusion of5 mg zoledronic acidshow a marked efficacy of this intervention in the treatment of primary and secondary osteoporosis with a combination of fracture risk reduction and prevention of bone loss at key skeletal sites. Rec...

詳細記述

書誌詳細
出版年:Остеопороз и остеопатии
主要な著者: S Yu Vorotnikova, E A Pigarova
フォーマット: 論文
言語:英語
出版事項: Endocrinology Research Centre 2016-12-01
主題:
オンライン・アクセス:https://endojournals.ru/index.php/osteo/article/view/9203

類似資料